The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Modulation of breast cancer cell-free DNA with surgical resection.
Howard B. Urnovitz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Julia Beck
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Ekkehard Schütz
Employment or Leadership Position - Chronix Biomedical
Stock Ownership - Chronix Biomedical
Gopal Singh
No relevant relationships to disclose
William M. Mitchell
Employment or Leadership Position - Chronix Biomedical (U)
Stock Ownership - Chronix Biomedical
Dalliah M. Black
No relevant relationships to disclose
Gildy Babiera
No relevant relationships to disclose
Isabelle Bedrosian
No relevant relationships to disclose
Henry Mark Kuerer
No relevant relationships to disclose
Gordon B. Mills
No relevant relationships to disclose
Funda Meric-Bernstam
No relevant relationships to disclose